• HC-5 HC-5 Remuneration of Approved Persons

    • HC-5.1 HC-5.1 Principle

      • HC-5.1.1

        The licensee must remunerate approved persons fairly and responsibly.

        October 2019

    • HC-5.2 HC-5.2 Remuneration Structure

      • HC-5.2.1

        The Board of Directors must:

        (a) Review the licensee's remuneration policies and amounts for approved persons taking into account total remuneration including salaries, fees, expenses and employee benefits which must be approved by the shareholders; and
        (b) Recommend Board members remuneration based on their attendance and performance.
        October 2019

      • HC-5.2.2

        Remuneration (including incentives, bonuses and other rewards) of approved persons must be sufficient enough to attract, retain and motivate persons of the quality needed to run the licensee successfully, but the licensee must avoid paying more than is necessary for that purpose.

        October 2019

      • HC-5.2.3

        Where remuneration is structured so as to link rewards to corporate and individual performance, criteria should avoid excessive focus on short-term profitability measures, without due regard to the longer-term consequences of actions taken.

        October 2019

      • Alignment of All Staff Remuneration with Compliance with AML/CFT Requirements

        • HC-5.2.4

          The performance evaluation and remuneration of senior management and staff of the licensee must be based on the achievement of the Key Performance Indicators (KPIs) relevant to ensuring compliance with AML/CFT requirements as specified in Paragraphs FC-2.1.3 and FC-2.1.4.

          Added: April 2020

    • HC-5.3 HC-5.3 Directors' Remuneration

      • HC-5.3.1

        The review of Directors' remuneration must be a standing item on the licensee's Annual General Meeting agenda, and must be considered by shareholders at every Annual General Meeting. Directors' remuneration and bonuses to executive directors must be clearly disclosed in the annual financial statements.

        October 2019

      • HC-5.3.2

        Directors' remuneration should also comply with all applicable laws, such as Legislative Decree No. 21 of 2001, with respect to promulgating the Commercial Companies Law.

        October 2019

      • HC-5.3.3

        Remuneration of non-executive directors must not include performance-related elements such as grants of shares, share options or other deferred stock-related incentive schemes, bonuses, or pension benefits.

        October 2019

    • HC-5.4 HC-5.4 Senior Management Remuneration

      • HC-5.4.1

        Remuneration of senior management must be structured so that a portion of the total is linked to licensee and individual performance and aligns their interests with the interests of the shareholders.

        October 2019

      • HC-5.4.2

        Such rewards may include grants of shares, share options and other deferred stock-related incentive schemes, bonuses, and pension benefits which are not based on salary.

        October 2019

      • HC-5.4.3

        If a senior manager is also a director, his remuneration as a senior manager must take into account compensation received in his capacity as a director.

        October 2019

      • HC-5.4.4

        All share incentive plans must be approved by the shareholders.

        October 2019

      • HC-5.4.5

        All performance-based incentives should be awarded under written objective performance standards which have been approved by the Board and are designed to enhance shareholder and company value, and under which shares should not vest and options should not be exercisable within less than two years of the date of award of the incentive.

        October 2019

      • HC-5.4.6

        All policies for performance-based incentives should be approved by the shareholders, but the approval should be only of the plan itself and not of the grant to specific individuals of benefits under the plan.

        October 2019